---
figid: PMC10266771__jci-133-171104-g258
figtitle: Proposed mechanism for the regulation of NRAS mutation-driven hematopoietic
  malignancies involves the CBL/JAK2/RAB27B signaling axis
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10266771
filename: PMC10266771__jci-133-171104-g258.jpg
figlink: /pmc/articles/PMC10266771/figure/F1
number: F1
caption: Deletion or loss-of-function mutations of CBL stabilize JAK2, leading to
  upregulation of the transcription of RAB27B. RAB27B facilitates NRAS trafficking
  to the plasma membrane and regulates its palmitoylation, thereby activating the
  RAS/RAF/MEK/ERK signaling pathway and promoting leukemogenesis
papertitle: Mechanisms for regulation of RAS palmitoylation and plasma membrane trafficking
  in hematopoietic malignancies
reftext: Fang Yu, et al. J Clin Invest. 2023 Jun 15;133(12).
year: '2023'
doi: 10.1172/JCI171104
journal_title: The Journal of Clinical Investigation
journal_nlm_ta: J Clin Invest
publisher_name: American Society for Clinical Investigation
keywords: ''
automl_pathway: 0.9627451
figid_alias: PMC10266771__F1
figtype: Figure
redirect_from: /figures/PMC10266771__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10266771__jci-133-171104-g258.html
  '@type': Dataset
  description: Deletion or loss-of-function mutations of CBL stabilize JAK2, leading
    to upregulation of the transcription of RAB27B. RAB27B facilitates NRAS trafficking
    to the plasma membrane and regulates its palmitoylation, thereby activating the
    RAS/RAF/MEK/ERK signaling pathway and promoting leukemogenesis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CBL
  - JAK2
  - RAB27B
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - EPHB2
  - MAPK1
  - MAPK3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - ZDHHC9
  - Fatty acid
  - Leukemia
---
